Get the Stockscreener App
1.0497
0.93%
0.0097
After Hours:
1.05
0.0003
+0.03%
Therapeuticsmd Inc stock is traded at $1.0497, with a volume of 17,787.
It is up +0.93% in the last 24 hours and down -5.40% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.04
Open:
$1.06
24h Volume:
17,787
Relative Volume:
0.96
Market Cap:
$12.15M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-1.9806
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-0.03%
1M Performance:
-5.40%
6M Performance:
+6.05%
1Y Performance:
-33.56%
1-Day Range:
$1.03
$1.06
1-Week Range:
$1.03
$1.09
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.0497 | 12.04M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Can TherapeuticsMD Inc. stock surprise with earnings upsideJuly 2025 Outlook & Daily Volume Surge Signals - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
How to forecast TherapeuticsMD Inc. trends using time seriesJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Will TherapeuticsMD Inc. price bounce be sustainableMarket Activity Report & Weekly Breakout Stock Alerts - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recoveryJuly 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
How to read the order book for TherapeuticsMD Inc.Market Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
TherapeuticsMD Inc. stock prediction for this weekJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Real time scanner hits for TherapeuticsMD Inc. explainedRisk Management & Free Community Consensus Stock Picks - newser.com
Will TherapeuticsMD Inc. stock go up soonJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock reacts to weak economyJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycleEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Is TherapeuticsMD Inc. stock attractive for hedge fundsJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Up 93.5% in September - Defense World
What analysts say about TherapeuticsMD Inc stockTrendline Breakouts & Minimal Capital Investment - earlytimes.in
Is TherapeuticsMD Inc. (29TA) stock a good hedge against inflationExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-10-05 04:45:14 - newser.com
Forecasting TherapeuticsMD Inc. price range with options dataWeekly Stock Recap & High Yield Equity Trading Tips - newser.com
Real time pattern detection on TherapeuticsMD Inc. stockFed Meeting & Real-Time Volume Analysis Alerts - newser.com
TherapeuticsMD Inc 29TA Stock Analysis and ForecastBearish Engulfing Patterns & Small Investment Growth Plans - earlytimes.in
TherapeuticsMD Inc Stock Analysis and ForecastTrade Execution Strategies & Rapid Capital Appreciation - earlytimes.in
What analysts say about TherapeuticsMD Inc 29TA stockMarket Volatility Update & Interactive Charts for Smarter Trading - earlytimes.in
What drives TherapeuticsMD Inc stock priceRisk Adjusted Returns & Small Budget Wealth Building - earlytimes.in
Is TherapeuticsMD Inc a good long term investmentDividend Yield Trends & Free Expert Guidance For Growth - Early Times
Intraday pattern recognizer results for TherapeuticsMD Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - newser.com
TherapeuticsMD Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Can TherapeuticsMD Inc. rally from current levelsWeekly Trade Summary & Community Consensus Picks - newser.com
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):